Following non-submission
AWMSG advice |
||
| Status: Not endorsed (Statement of Advice) | ||
In the absence of a submission from the holder of the marketing authorisation, clevidipine (Cleviprex®) cannot be endorsed for use within NHS Wales for rapid reduction of blood pressure in the perioperative setting. |
||
|
||
Medicine details |
||
| Medicine name | clevidipine (Cleviprex®) | |
| Formulation | 0.5 mg/ml emulsion for injection | |
| Reference number | 384 | |
| Indication | Rapid reduction of blood pressure in the perioperative setting |
|
| Company | The Medicines Company | |
| BNF chapter | Cardiovascular system | |
| Assessment type | Non-submission | |
| Status | Not endorsed (Statement of Advice) | |
| Date of issue | 25/04/2012 | |